Kane Biotech Inc V.KNE

Alternate Symbol(s): KNBIF

Healthcare Biotechnology

Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.

TSXV:KNE - Post by User

Kane Biotech Inc

Bullboard Posts

Post by richsooneron Aug 25, 2012 3:28pm

175 Views

Post# 20260402

Management Too Quiet

Management needs to understand that shareholders want regular feedback. When we don't get regular feedback .. rumours & frustration begin to occur. It's a great company with a lot of potential but the SP is NOT reflecting that and part of the reason is the lack of feedback. Wake up management ... You have 2 duties:

1) Add value to the company

2) Keep shareholders INFORMED

Bullboard Posts

A potential breakthrough in spinal cord and optic nerve injury treatment